TAU vs m-SBIRT in Primary Care

Medical University of South Carolina (MUSC)

Status: Withdrawn

Conditions: Substance Use Disorders

Treatments: Behavioral: m-SBIRT (mobile-Screening, Brief Intervention, and Referral to Treatment)

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT06250153

Pro00133783

Details and patient eligibility

About

The goal of this research is to leverage technology in primary care clinics to improve screening, brief intervention and referral to Substance Use Disorder (SUD) treatment, and treatment attendance by comparing

1. a text message-based screening, phone-based brief intervention, and referral to treatment by a remote care coordinator (m-SBIRT; intervention arm), versus
2. evidence-based, in-person Screening, Brief Intervention, and Referral to Treatment (SBIRT; Treatment As Usual (TAU); control arm).

Primary Aim is to compare the efficacy of m-SBIRT to TAU in positive screens for substance use. Secondary Aim is to compare m-SBIRT to TAU on Substance Use Treatment Attendance.

Full description

This research study is looking at the use of technology in primary care clinics and seeing if it improves screening, brief intervention and referral to Substance Use Disorder (SUD) treatment, and attendance to treatment. To do so the study, Investigators will be comparing a text message based substance use screening and treatment program, called Mobile Screening, Brief intervention, and Referral to Treatment (m-SBIRT) to standard of care Screening, Brief Intervention and Referral Treatment which traditionally takes place in-person. Patients at the MUSC Bee Street Primary Care Clinic between the ages of 18-75 may be eligible.

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age 18-75
• Attended a primary care visit at the MUSC Family Medicine clinic on Bee St
• English fluency
• Owner of a cell phone with SMS text-message based capability
• Access to WIFI
• A device to allow audio and video teleconferencing if completing informed consent remotely
• Able to provide informed consent.

Exclusion criteria

• None

Trial design

Primary purpose: Screening

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups

Treatment as Usual

No Intervention group

Description:

This group will receive routine substance use screening questions during their in-person primary care visit as part of standard of care.

m-SBIRT (mobile-Screening, Brief Intervention, and Referral to Treatment)

Experimental group

Description:

This group will receive a mobile phone text message based substance use screening (questions used in standard of care) with immediate automated feedback, paired with remote care coordination and, if appropriate, referral to substance use disorder (SUD) treatment.

Treatment:

Behavioral: m-SBIRT (mobile-Screening, Brief Intervention, and Referral to Treatment)